Guided Therapeutics (GTHP) Revenue (Gross) (2023 - 2024)
Guided Therapeutics recorded quarterly Revenue (Gross) of $3000.0 in Q1 2024, down 50.0% quarter-over-quarter from $6000.0 in Q4 2023.
Guided Therapeutics' Revenue (Gross) history runs 2 years deep, the most recent figure standing at $3000.0 for Q1 2024.
- In Q1 2024, Revenue (Gross) changed N/A year-over-year to $3000.0; the TTM figure through Dec 2024 stood at $3000.0 (down 50.0% YoY), while the FY2024 annual figure was $3000.0, down 50.0% from the prior year.
- Revenue (Gross) came in at $3000.0 for Q1 2024 at Guided Therapeutics, down from $6000.0 in the prior quarter.
- In the past five years, Revenue (Gross) ranged from a high of $6000.0 in Q4 2023 to a low of $3000.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Gross) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Guided Therapeutics | - | - | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 6,000.00 |